DESIROX 250mg Tablets (Deferasirox) | Iron Chelation Medicine – Pharma Services Group

DESIROX 250mg Tablets contain deferasirox, an oral iron-chelating medicine used under specialist medical supervision to treat certain forms of chronic iron overload. Deferasirox is used for chronic iron overload associated with repeated blood transfusions and, in appropriately selected patients, chronic iron overload associated with non-transfusion-dependent thalassemia syndromes.

DESIROX 250mg (Deferasirox) tablets are shown in the supplied product image with the Glitz brand/manufacturer marking. Deferasirox works by binding excess iron in the body so that it can be eliminated. Treatment is generally considered only when clinical evidence indicates significant iron overload, and the appropriate dose is determined according to the patient’s condition, body weight, iron levels, kidney function, liver function, and treatment response.

Deferasirox 250mg tablets require careful medical monitoring. Healthcare professionals may monitor serum ferritin, kidney function, liver function and other relevant laboratory parameters during treatment. Deferasirox can cause serious kidney, liver, gastrointestinal, blood-count, hearing, or vision-related adverse effects, so patients should follow their prescriber’s monitoring schedule.

DESIROX 250mg is a prescription medicine and should only be used under the direction of a qualified healthcare professional. Do not self-medicate with deferasirox or change the prescribed dose. The correct dosage and administration depend on the specific formulation and the patient’s clinical condition.

Product Information

• Brand Name: DESIROX
• Active Ingredient: Deferasirox
• Strength: 250mg
• Dosage Form: Tablet
• Therapeutic Class: Iron chelator
• Primary Use: Management of certain forms of chronic iron overload
• Manufacturer/Brand Shown: Glitz
• Prescription Status: Prescription medicine
• Pack Size: Not clearly visible on the supplied image